General Information of Drug Transporter (DT)
DT ID	DTD0013 Transporter Info
Gene Name	ABCB4
Protein Name	Multidrug resistance protein 3
Gene ID	5244
UniProt ID	P21439
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs1149222
Site of GPD	chr7:87444459 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>T
Minor Allele Frequency	G=0.3842/1924 (Global)
Allele G	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele T)		[ 1]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele T)		[ 1]
Anthracyclines	N.A.	Neoplasm	Correlated with the increased likelihood of cardiotoxicity in patients (compare with Allele T)		[ 2]
Genetic Polymorphism	rs4148808
Site of GPD	chr7:87476479 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.2206/1105 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Anthracyclines	N.A.	Neoplasm	Correlated with the increased likelihood of cardiotoxicity in patients (compare with allele C)		[ 2]
References
1	Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81.
2	Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.